letermovir
MSD’s investigational cytomegalovirus treatment shows significant promise in Phase 3 trial
February 27, 2017Research and Development, Sales and Marketing MSD, cytomegalovirus, letermovir
MSD has lifted the curtain on strong Phase 3 results in the development of its investigational antiviral drug letermovir, showing …
MSD’s antiviral drug hits endpoint targets in Phase III trials
October 20, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AiCuris, MSD, Merck, bone marrow, letermovir, transplant
MSD, known as Merck in the US, released news of the successful meeting of its primary endpoints in its Phase …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
